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Classical Hodgkin lymphoma (cHL) is one of the most com-
mon malignancies affecting young adults and has a good
prognosis in this group. The unusual composition of cells in
cHL, consisting of less than 1% of tumour cells and 99% of
reactive infiltrate, has intrigued scientists for a long time.
The microenvironment in cHL is now thought to produce
survival signals as well as serve as a physical barrier against
immune responses. The tumour cells however, largely deter-
mine which cells are attracted to the affected lymph node by
producing several chemokines and cytokines and, in addi-
tion, actively suppress an immune response by the produc-
tion of suppressive factors, expression of inhibitory immune
checkpoints and the loss of human leucocyte antigen (HLA)
expression (Liu et al, 2014). In the last 2 decades, the role of
the microenvironment, particularly its composition, has
become increasingly important in the prognosis of cHL. This
includes increased numbers of eosinophils (Enblad et al,
1993), mast cells (Molin et al,2002), T regulatory cells (Hol-
lander et al, 2017) and macrophages (Steidl et al, 2010), all
of which cause a worse prognosis. So far, this has not
affected treatment decisions.
A new paper (Gholiha et al, 2019) in this issue of the
British Journal of Haematology, explored the role of plasma
cells in the survival and clinical parameters of cHL. This
study investigated a more recent Swedish patient cohort of
120 patients, collected within 3 years and with uniform
modern treatment. These patients have been used for other
studies in the past and several data on other parameters
were available for comparison with the newly collected data.
Tissue biopsies were stained for CD138 and IgG4 and
scored by both digital analysis and manual scoring. Plasma
cell infiltration (≥1%) was found in 70 out of 120 patients,
while high plasma cell infiltration (≥10%) was found in 8
patients. High plasma cell infiltration was associated with B-
symptoms, advanced stage, eosinophil numbers and inferior
survival.
That plasma cells are associated with B symptoms and
have a role in the prognosis of cHL is new. The particular
strength of this paper is the patient cohort, which has been
treated uniformly and according to recent protocols.
What we still need to figure out is how do plasma cells
access the microenvironment and whether there is a role for
plasma cells in cHL.
In cHL, plasma cells can be attracted by CCL28 or the
presence of cytokines, such as interleukin IL-6 and IL-21,
can play a role in the differentiation of plasma cells. Both
CCL28 and the interleukins are produced by the Hodgkin
and Reed–Sternberg cells in cHL. CCL28 is produced in
approximately 80% of HL cases (Hanamoto et al, 2004) and
also attracts eosinophils, which would fit with their increased
numbers. Serum levels of IL-6 are indeed associated with
B-symptoms (Gaiolla et al, 2011), and high levels (>30 pg/
ml) are found in 23% of HL cases (Casasnovas et al, 2007).
It is interesting to correlate IL-6 and CCL28 levels with the
presence of plasma cells in the microenvironment to answer
the first part of the question. Is there a role for plasma cells
in cHL is more difficult to answer, as we have no clues
regarding which factors these cells produce that are advanta-
geous in any way for tumour cells. For now, we should con-
sider them as a by-product of the large number of factors
produced by the tumour cells in cHL.
Do B-symptoms (night sweats, fever and/or weight loss)
need to be treated? So far, it seems that the tumour cells them-
selves are responsible for these symptoms, so eliminating the
tumour cells usually affects the B-symptoms as well. Will this
finding affect the way clinicians treat their patients? Not very
likely – although an effective and easy to implement tool that
would predict the effect of treatment is really needed. This is
especially important in young adults, where the long-term
effects of a harsh treatment can be felt and should be prevented
when possible. None of the markers produced so far are robust
enough to use, including the newly reported plasma cells.
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What we can learn from this paper is that plasma cells
play a role in the microenvironment of cHL next to macro-
phages, eosinophils and T regulatory cells. In addition, high
numbers of plasma cells may cause B-symptoms and have an
inferior effect on prognosis. This will not lead to changes in
the treatment of cHL directly, but our image of the microen-
vironment is more complete and will contribute to the use
of therapies tackling the microenvironment in cHL.
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